The European Commission has launched the Horizon Prize for Better Use of Antibiotics to stimulate innovative thinking and find solutions to the growing problem of antimicrobial resistance. It is a challenge prize offering a cash reward of €1 million to whoever can most effectively meet the following challenge: Develop a rapid test that will allow healthcare providers to distinguish, at the point of care, between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without them....

Business model options for antibiotics: learning from other industries Chatham House and Big Innovation Centre have released a research report offering a number of innovative models and ideas that address many of the critical questions facing policy-makers in the EU and the US as they seek solutions to the misalignment between the need for new antimicrobials and the incentives, or lack thereof, for their development. Released on February 24, 2015. Authors: E. Jaczynska, K. Outterson, and J. Mestre-Ferrandiz...

Geneva, Switzerland, Monday 6^th October 2014 - DRIVE-AB (Driving Reinvestment in R&D and Responsible Antibiotic Use), a public-private consortium funded by the EU Innovative Medicines Initiative (IMI), was delighted to hold its inaugural meeting which announced the launch of a €9.3million project to tackle the dual crisis of antimicrobial resistance and re-stimulate Pharma interest in antibiotic research and development. Antimicrobial resistance (AMR). Through a series of plenary discussions and break out sessions the expert consortium looked at work plans for delivering new economic models for antibiotic discovery and development and evaluation of the responsible use of new and old...